查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762405

主髂动脉阻塞性疾病治疗市场规模、占有率、产业分析报告：依设备类型、治疗方案、最终用途、地区，预测至2025-2034年

Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2034年，主髂动脉阻塞性疾病治疗市场规模将达35.6亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

主髂动脉闭塞性疾病治疗市场包括主动脉和髂动脉阻塞的医疗和外科治疗，这些阻塞通常由动脉粥状硬化引起。糖尿病、高血压和肥胖等慢性疾病的发生率上升，推动了对血管内和开放手术的临床需求。血管内治疗，尤其是血管成形术和支架置入术，因其併发症发生率低、住院时间短、患者预后好等特点，已成为首选的治疗方法。

市场成长得益于器械技术的进步，包括药物洗脱支架、生物可吸收支架和影像引导导航系统，这些技术提高了精准度和长期疗效。业内人士正致力于混合血运重建技术，以治疗复杂病变和多层闭塞，为最佳化治疗方案开闢新途径。此外，门诊血管中心也越来越倾向于进行大量微创手术。随着早期发现、风险分层和生活方式改变计划的日益重视，整合照护模式的重要性日益凸显。

影像、人工智慧和血管机器人技术的融合逐渐改变治疗模式，为更个人化、资料驱动的医疗服务铺路。临床试验和上市后监测方面的投入持续为器材的安全性、耐用性和性能提供指标。机会在于扩大医疗资源匮乏人群获得下一代疗法的管道，并改进治疗演算法以改善高风险患者的预后。市场正稳步发展，朝着技术含量更高、更注重疗效的生态系统迈进，并致力于手术效率、长期通畅率和患者生活品质。

主动脉阻塞性疾病治疗市场报告重点

依器械类型划分，血管内器械领域在2024年占据最大占有率，这主要是因为在治疗主动脉-髂动脉闭塞性疾病方面，微创手术的趋势日益明显。

依最终用途划分，医院领域在2024年占据最大占有率，这得益于其能够处理需要多学科团队、先进影像和手术支援的高风险病例。

2024年，由于先进的血管内治疗、强有力的偿付制度和早期诊断实践的广泛应用，北美主动脉-髂动脉闭塞性疾病治疗市场占据最大占有率。

由于医疗保健可近性的改善、医疗基础设施的扩大以及人们对血管疾病的认识的提高，预计亚太地区主髂动脉阻塞性疾病治疗市场在预测期内将实现最高的年复合成长率。

全球主要公司包括Abbott、BD、Bentley InnoMed、Biotronik SE &Co KG、Boston Scientific Corporation、Cook、Getinge AB、iVascular、Medtronic、Scitech Medical、Terumo Corporation、W. L. Gore &Associates, Inc.。

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球主髂动脉阻塞性疾病治疗市场洞察

  • 市场概况
  • 主髂动脉阻塞性疾病治疗市场动态
    • 驱动因素与机会
      • 週边动脉疾病（PAD）盛行率上升
      • 老化人口成长
    • 限制因素与挑战
      • 先进治疗方案成本高昂
  • PESTEL 因素分析
  • 主髂动脉阻塞性疾病治疗市场趋势
  • 价值链分析

第5章 全球主髂动脉阻塞性疾病治疗市场（依设备类型）

  • 主要调查结果
  • 简介
  • 血管内器械
  • 外科器械

第6章 全球主髂动脉阻塞性疾病治疗市场（依手术方式）

  • 主要调查结果
  • 简介
  • 血管内手术
  • 混合手术
  • 开放式手术

第7章 全球主髂动脉阻塞性疾病治疗市场（依最终用途）

  • 关键调查结果
  • 引言
  • 医院
  • 门诊设施
  • 其他

第8章 全球主髂动脉阻塞性疾病治疗市场（依地区）

  • 主要调查结果
  • 引言
    • 2020-2034年主髂动脉阻塞性疾病治疗市场评估（依地区）
  • 北美
    • 2020-2034年北美：依设备类型
    • 2020-2034年北美：依手术
    • 2020-2034年北美：依最终用途
    • 美国
    • 加拿大
  • 欧洲
    • 2020-2034年欧洲：依设备类型
    • 2020-2034年欧洲：依手术
    • 2020-2034年欧洲：依最终用途
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 2020-2034年亚太地区：依设备类型
    • 2020-2034年亚太地区：依手术
    • 2020-2034年亚太地区：依最终用途
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区国家
  • 中东和非洲
    • 2020-2034年中东和非洲：依设备类型
    • 2020-2034年中东和非洲：依手术
    • 2020-2034年中东和非洲：依最终用途
    • 沙乌地阿拉伯 RABIA
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 中东和非洲其他地区
  • 拉丁美洲
    • 2020-2034年拉丁美洲：依设备类型
    • 2020-2034年拉丁美洲：依手术
    • 2020-2034年拉丁美洲：依最终用途
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区

第9章 竞争格局

  • 扩张与收购分析
    • 扩张
    • 收购
  • 合作伙伴/合作/协议/公开

第10章 公司简介

  • Abbott
  • BD.
  • Bentley InnoMed
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Cook
  • Getinge AB
  • iVascular
  • Medtronic
  • Scitech Medical
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Product Code: PM5750

The aorto-iliac occlusive disease treatment market size is expected to reach USD 3.56 billion by 2034, according to a new study by Polaris Market Research. The report "Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The aorto-iliac occlusive disease treatment market addresses the medical and surgical management of arterial blockages occurring in the aorta and iliac arteries, typically caused by atherosclerosis. The increasing prevalence of chronic conditions such as diabetes, hypertension, and obesity has intensified clinical demand for both endovascular and open surgical interventions. Endovascular procedures, particularly angioplasty and stenting, have become the preferred therapeutic approach due to their lower complication rates, reduced hospital stays, and improved patient outcomes.

Market growth is supported by advancements in device technologies, including drug-eluting stents, bioresorbable scaffolds, and image-guided navigation systems, which enhance precision and long-term efficacy. Industry players are focusing on hybrid revascularization techniques to treat complex lesions and multilevel occlusions, creating new avenues for treatment optimization. There is also a rising trend toward outpatient vascular care centers, where minimally invasive interventions are being performed in high volumes. Increasing emphasis on early detection, risk stratification, and lifestyle modification programs has elevated the importance of integrated care models.

The convergence of diagnostic imaging, artificial intelligence, and vascular robotics is gradually transforming the treatment paradigm, paving the way for more personalized, data-driven interventions. Investments in clinical trials and post-market surveillance studies continue to inform device safety, durability, and performance metrics. Opportunities lie in expanding access to next-generation therapies in underserved populations and refining treatment algorithms to improve outcomes in high-risk patients. The market is steadily evolving into a more technologically enabled, outcome-focused ecosystem that emphasizes procedural efficiency, long-term patency, and patient quality of life.

Aorto-Iliac Occlusive Disease Treatment Market Report Highlights

By device type, in 2024, the endovascular devices segment captured the largest share, primarily driven by the increasing preference for minimally invasive surgery in managing aorto-iliac occlusive disease.

Based on end use, in 2024, the hospitals segment accounted for the largest share, fueled by their capacity to manage high-risk cases requiring multidisciplinary teams, advanced imaging, and surgical backup.

In 2024, the North America aorto-iliac occlusive disease treatment market accounted for the largest share due to the widespread use of advanced endovascular procedures, strong reimbursement frameworks, and early diagnosis practices.

The Asia Pacific aorto-iliac occlusive disease treatment market is projected to register the highest CAGR during the forecast period due to rising healthcare access, expanding medical infrastructure, and increasing awareness of vascular conditions.

A few global key players include Abbott; BD.; Bentley InnoMed; Biotronik SE & Co KG; Boston Scientific Corporation; Cook; Getinge AB; iVascular; Medtronic; Scitech Medical; Terumo Corporation; W. L. Gore & Associates, Inc.; and ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Polaris Market Research has segmented the aorto-iliac occlusive disease treatment market on the basis of device type, procedure, end use, and region:

By Device Type Outlook (Revenue, USD Billion, 2020-2034)

Endovascular Devices

Balloon Angioplasty Devices

Atherectomy Systems

Stents

Surgical Devices

By Procedure Outlook (Revenue, USD Billion, 2020-2034)

Endovascular Procedures

Hybrid Procedures

Open Surgical Procedures

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Outpatient Facilities

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Aorto-Iliac Occlusive Disease Treatment Market Insights

  • 4.1. Aorto-Iliac Occlusive Disease Treatment Market - Market Snapshot
  • 4.2. Aorto-Iliac Occlusive Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Peripheral Arterial Disease (PAD)
      • 4.2.1.2. Growing Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Advanced Treatments
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Aorto-Iliac Occlusive Disease Treatment Market Trends
  • 4.6. Value Chain Analysis

5. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • 5.3. Endovascular Devices
    • 5.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Devices, by Region, 2020-2034 (USD Billion)
  • 5.4. Surgical Devices
    • 5.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Surgical Devices, by Region, 2020-2034 (USD Billion)

6. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • 6.3. Endovascular Procedures
    • 6.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Procedures, by Region, 2020-2034 (USD Billion)
  • 6.4. Hybrid Procedures
    • 6.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hybrid Procedures, by Region, 2020-2034 (USD Billion)
  • 6.5. Open Surgical Procedures
    • 6.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Open Surgical Procedures, by Region, 2020-2034 (USD Billion)

7. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Outpatient Facilities
    • 7.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Outpatient Facilities, by Region, 2020-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Aorto-Iliac Occlusive Disease Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Aorto-Iliac Occlusive Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Aorto-Iliac Occlusive Disease Treatment Market - North America
    • 8.3.1. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.3.3. North America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Aorto-Iliac Occlusive Disease Treatment Market - U.S.
      • 8.3.4.1. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Aorto-Iliac Occlusive Disease Treatment Market - Canada
      • 8.3.5.1. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Aorto-Iliac Occlusive Disease Treatment Market - Europe
    • 8.4.1. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Aorto-Iliac Occlusive Disease Treatment Market - UK
      • 8.4.4.1. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Aorto-Iliac Occlusive Disease Treatment Market - France
      • 8.4.5.1. France: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Aorto-Iliac Occlusive Disease Treatment Market - Germany
      • 8.4.6.1. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Aorto-Iliac Occlusive Disease Treatment Market - Italy
      • 8.4.7.1. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Aorto-Iliac Occlusive Disease Treatment Market - Spain
      • 8.4.8.1. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Aorto-Iliac Occlusive Disease Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Aorto-Iliac Occlusive Disease Treatment Market - Russia
      • 8.4.10.1. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Aorto-Iliac Occlusive Disease Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Aorto-Iliac Occlusive Disease Treatment Market - China
      • 8.5.4.1. China: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Aorto-Iliac Occlusive Disease Treatment Market - India
      • 8.5.5.1. India: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Aorto-Iliac Occlusive Disease Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Aorto-Iliac Occlusive Disease Treatment Market - Japan
      • 8.5.7.1. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Aorto-Iliac Occlusive Disease Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Aorto-Iliac Occlusive Disease Treatment Market - South Korea
      • 8.5.9.1. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Aorto-Iliac Occlusive Disease Treatment Market - Australia
      • 8.5.10.1. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Aorto-Iliac Occlusive Disease Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Aorto-Iliac Occlusive Disease Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Aorto-Iliac Occlusive Disease Treatment Market - UAE
      • 8.6.5.1. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Aorto-Iliac Occlusive Disease Treatment Market - Israel
      • 8.6.6.1. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Aorto-Iliac Occlusive Disease Treatment Market - South Africa
      • 8.6.7.1. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Aorto-Iliac Occlusive Disease Treatment Market - Latin America
    • 8.7.1. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Aorto-Iliac Occlusive Disease Treatment Market - Mexico
      • 8.7.4.1. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Aorto-Iliac Occlusive Disease Treatment Market - Brazil
      • 8.7.5.1. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Aorto-Iliac Occlusive Disease Treatment Market - Argentina
      • 8.7.6.1. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BD.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bentley InnoMed
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Biotronik SE & Co KG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Boston Scientific Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Cook
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Getinge AB
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. iVascular
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Medtronic
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Scitech Medical
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Terumo Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. W. L. Gore & Associates, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development

List of Tables:

  • Table 1 Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 2 Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 3 Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 5 North America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 6 North America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 9 U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 12 Canada: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 15 Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 17 UK: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 18 UK: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 20 France: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 21 France: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 24 Germany: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 27 Italy: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 30 Spain: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 36 Russia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 44 China: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 45 China: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 47 India: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 48 India: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 54 Japan: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 60 South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 63 Australia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 75 UAE: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 78 Israel: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 81 South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 87 Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 90 Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 93 Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 96 Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Aorto-Iliac Occlusive Disease Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Device Type
  • Figure 7. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Procedure
  • Figure 9. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2024 & 2034 (USD Billion)